UNC Pleural Fluid Registry
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT05620329
- Status
- Recruiting
Conditions
- Breast Cancer
- Empyema
- Lung Cancer
- Lung Infection
- Malignant Pleural Effusion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.
Key Dates
- Start date
- Jan 24, 2018
- Status verified
- Oct 2025
- Primary completion
- Jan 24, 2050
- Completion
- Jan 24, 2050
Study Design
- Enrollment
- 9,999 participants (estimated)
Arms
- Arm: Pleural Fluid RegistryAny subject who has pleural fluid buildup from lung cancer, breast cancer, or lung infection
Primary Outcome Measure
Creation of a pleural fluid registry [ Time Frame: 32 years ]
Central Contacts
- Carmmen Garcia+1 954-336-7499
- Luz Cuaboy+1 954-336-7499
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UNC Lingeberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | Luz Cuaboy Jason Akulian, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
By condition
By research site
Related Studies
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California